Analysis

Bio-rad Laboratories, Inc. (BIO) Stock Analysis

Bio-rad Laboratories, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to BIO.

websiteBIO/analysis/BIO

Bio-rad Laboratories, Inc.

Bio-rad Laboratories, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to BIO.

Stock profile

Ticker

BIO

Asset type

Stock

Market cap

$7.65B

Sector

Health Technology

Industry

Medical Specialties

Currency

USD

Ticker listings

Bio-rad Laboratories, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • BIO primary listing
  • BIO.B
  • BUWA
  • 865406
  • BUW
  • 862449

Latest Bio-rad Laboratories, Inc. news

Bio-Rad to Participate in Upcoming Investor Conferences

HERCULES, Calif., May 08, 2026--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced tha...

Bio-Rad Reports First-Quarter 2026 Financial Results

HERCULES, Calif., April 30, 2026--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced f...

Bio-Rad to Report First-Quarter 2026 Financial Results on Thursday, April 30, 2026

HERCULES, Calif., April 16, 2026--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its f...

Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results

HERCULES, Calif., February 12, 2026--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announce...

Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026

HERCULES, Calif., January 29, 2026--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its...

Research sections

Valuation

Review valuation context for Bio-rad Laboratories, Inc..

Future growth

Review future growth context for Bio-rad Laboratories, Inc..

Past performance

Review past performance context for Bio-rad Laboratories, Inc..

Financial health

Review financial health context for Bio-rad Laboratories, Inc..

Dividend

Review dividend context for Bio-rad Laboratories, Inc..

Management

Review management context for Bio-rad Laboratories, Inc..

Ownership

Review ownership context for Bio-rad Laboratories, Inc..

Other information

Review other information context for Bio-rad Laboratories, Inc..

Community

Review community context for Bio-rad Laboratories, Inc..